NEW ORLEANS -- Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, raising its prospects as an investigational neuroprotective therapy. In ...
Hello. Good morning and good afternoon, everybody, and welcome to our investor webinar on the results of the OCEANIC-STROKE Phase III trial directly live from ISC 2026 in New Orleans. So my name is ...
An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic (clot-caused) stroke without raising bleeding concerns, according to a preliminary ...
NEW ORLEANS -- A stronger case could be made for intra-arterial (IA) alteplase after successful mechanical thrombectomy based on more randomized data, this time the CHOICE-2 trial from Spain. In acute ...
Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Xiong and colleagues should ...
Purpose Large-scale stroke registries can provide critical insights into disease mechanisms, progression and healthcare needs, informing prevention and care. However, few collect detailed demographic, ...
Introduction: Door-in-door-out (DIDO) time may impact outcomes in ischemic stroke patients with large vessel occlusions (LVO). The effect of LVO location and clinical presentation on DIDO has not been ...
Introduction: Stroke education is a key determinant of timely hospital arrival. While considerable evidence indicates that Black patients experience greater prehospital delay, few studies have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results